This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Aug. 15, 2012

Home  About Us  Advocacy   CSHP 2015   Events   Membership   Products & Publications   Programs Resources   Contact Us


Pharmacy Shelving and much more!

Complete pharmacy solutions: Shelving, under-counter, etc.
All in metal.
Call now for a free quote. 888-864-9322.


RxFiles Drug Comparison Charts


- Book: New 9th
  Editions
- Online:
www.RxFiles.ca
- Apps: iPad &
  Android

 




Disclaimer: CSHP e-Newsbrief is a weekly listing featuring the latest news in hospital pharmacy selected from thousands of sources by the editors of MultiView. CSHP personnel approve the final summaries: any comments regarding content or this new publication should be emailed to CSHP. The presence of advertising does not endorse, or imply endorsement of, any products or services by the CSHP. Neither MultiView nor CSHP is liable for any inaccuracies or the use of or reliance on any information contained in this briefing, with the exception of CSHP news items.



In this issue:

New non-toxic disinfectant could tackle hospital infections
Campbellford Memorial Hospital meets drug challenges head on
Whooping cough vaccine bid by N.B. pharmacists rejected
Drug coverage approved to treat rare condition
Bulk buying drugs will reduce health care costs
New Herceptin formulation allows delivery via injection
Provinces must take steps to cut drug costs
Diet pill market about to get heavier: makers of weight loss drug to seek Health Canada approval
CDC recommends HIV prevention pill for at-risk women, heterosexual men


New non-toxic disinfectant could tackle hospital infections
e! Science News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new disinfectant, Akwaton, that works at extremely low concentrations could be used in healthcare settings to help control persistent hospital-acquired infections such as Clostridium difficile. The study is reported online in the Journal of Medical Microbiology. Researchers from the Université de Saint-Boniface in Winnipeg, Canada tested the new compound, Akwaton, against bacterial spores that attach to surfaces and are difficult to destroy. More



Campbellford Memorial Hospital meets drug challenges head on
Northumberland News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A drug shortage in Canada has Campbellford Memorial Hospital prepared and ahead of the curve. CMH president and CEO Brad Hilker said the shortage hasn't affected the hospital and it's staying diligent in efforts to provide the best care for patients. The cause of the shortage is a reduction in production by the pharmaceutical company Sandoz at its facilities in Quebec, where it has faced a number of issues including a fire, he said. More

Whooping cough vaccine bid by N.B. pharmacists rejected
CBC    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Health Minister Madeline Dubé has turned down a request by New Brunswick pharmacists to be allowed to administer whooping cough vaccines. Dubé says there are sufficient immunization providers to handle the current outbreak in the province. But Alistair Bursey, president of the New Brunswick Pharmacists Association, disagrees. More

Drug coverage approved to treat rare condition
The Daily Herald    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Saskatchewan's Ministry of Health has added a new drug to treat a rare enzyme deficiency condition. The request to cover Naglazyme was received by the Saskatchewan Drug Plan on behalf of a three-year old Langenburg resident who has mucopolysaccharidosis VI (MPS VI). The decision took into consideration the drug's clinical effectiveness, cost and safety implications. More

Bulk buying drugs will reduce health care costs
The Montreal Gazette    Share    Share on FacebookTwitterShare on LinkedinE-mail article
At the recent Council of the Federation meeting, Canadian provinces (except Quebec) announced that they will begin bulk-buying different generic drugs to reduce health care costs. They also flagged the need to both expand and accelerate group pricing on brand name pharmaceuticals. More

New Herceptin formulation allows delivery via injection
In-Pharmatechnologist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new formulation of Genetech's breast cancer drug Herceptin means patients could soon receive treatment via injection, rather than time consuming intravenous drip. Currently, those receiving Herceptin — or trastuzumab — must spend 90 minutes in hospital on a drip in the first instance, followed by 30 minute dosages on site once every three weeks. More

Provinces must take steps to cut drug costs
Times Colonist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Recently, at the conclusion of interprovincial health-care discussions in Halifax, Canada's premiers and territorial leaders announced their plan to jointly purchase some generic drugs. A worthwhile initiative, but it is just one step of several required to support public health care by reducing the rising cost of prescription drugs, and getting full value for tax dollars. More

Diet pill market about to get heavier: makers of weight loss drug to seek Health Canada approval
Canada.com    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A weight-loss drug recently approved for use in the U.S. may be headed for Canada — a move that could mark a turning point in a controversial corner of medicine that last saw a new drug approved more than a decade ago. The makers of Belviq say they are poised to market their drug in Canada, a plan that, if approved, would double Canada's prescription diet pill market — from one drug to two. More

CDC recommends HIV prevention pill for at-risk women, heterosexual men
CTV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
U.S. health officials are telling doctors they should consider an AIDS prevention pill for women and heterosexual men at high risk for getting the virus. The government previously advised doctors to give the once-a-day pill Truvada to high-risk gay and bisexual men only. However, there are an estimated 140,000 heterosexual couples in which one person is infected with HIV. More


 


CSHP e-Newsbrief

Frank Humada, Director of Publishing, MultiView 289.695.5422
Download media kit

Siobhan Cole, Senior Content Editor, MultiView 289.695.5423   
Contribute news


To unsubscribe, click here.

Recent issues






50 Minthorn Blvd., Suite 800, Thornhill, ON, L3T 7X8